LOADING

Toursyn AI Closes Multi-Hundred-Million RMB Pre-A Rounds for AI Drug Design

Investment

Wuxi Toursyn AI raised multi-hundred-million RMB across Pre-A and Pre-A+ rounds to upgrade ToursynClaw, its one-stop AI drug-design platform. More deals: AI Investment.

© 版权声明

相关文章